Literature DB >> 17405869

Decrease in N-methyl-D-aspartic acid receptor-NR2B subunit levels by intrathecal short-hairpin RNA blocks group I metabotropic glutamate receptor-mediated hyperalgesia.

Bichoy H Gabra1, Fay K Kessler, Joseph K Ritter, William L Dewey, Forrest L Smith.   

Abstract

The present study characterizes the involvement of the N-methyl-D-aspartic acid receptors (NMDARs) in mediating thermal hyperalgesia induced by activation of group I metabotropic glutamate receptors (mGluRs). Intrathecal administration of the mGluR1/5 agonist (S)-3,5-DHPG [(S)-3,5-dihydroxyphenylglycine] to mice resulted in significant hyperalgesia as assessed by the tail immersion test. The pretreatment of mice i.t. with CGS 19755 (selective antagonist of the NMDAR), CGP 78608 [[(1S)-1-[[(7-bromo-1,2,3,4-tetrahydro-2,3-dioxo-5-quinoxalinyl)methyl]amino]ethyl]phosphonic acid] (selective antagonist at the glycine-binding site of the NMDAR), ifenprodil and Ro 25-6981 (selective antagonists of the NR2B subunit of the NMDAR), bisindolylmaleimide I and Go-7874 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] (inhibitors of protein kinase C), or PKI-(14-22)-amide [Myr-N-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH(2)] (inhibitor of protein kinase A) dose-dependently inhibited the hyperalgesia induced by i.t. administration of the mGluR1/5 receptor agonist (S)-3,5-DHPG. In contrast, i.t. pretreatment of mice with NVP-AAM077 [[(R)-[(S)-1-(4-bromophenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid] (selective antagonist of the NR2A subunit of the NMDAR) or DT-3 [H-Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-Leu-Arg-Lys-Lys-Lys-Lys-Lys-His-OH] (inhibitor of protein kinase G) had no effect on (S)-3,5-DHPG-mediated hyperalgesia. We also show for the first time that i.t. injection of pSM2 (pShag Magic version 2)-grin2b (coding for an short-hairpin RNA to the NR2B subunit of the NMDAR) resulted in a dose-dependent decrease in the NR2B protein and blockade of hyperalgesia induced by activation of the mGluR1/5 in (S)-3,5-DHPG-treated mice. Taken together, our results suggest the hypothesis that mGluRs are coupled to the NMDAR channels through the NR2B subunit in the spinal cord and that this coupling involves the activation of protein kinase C and protein kinase A.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17405869     DOI: 10.1124/jpet.107.120071

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Activation of group I mGlu receptors contributes to facilitation of NMDA receptor membrane current in spinal dorsal horn neurons after hind paw inflammation in rats.

Authors:  Kun Yang; Keita Takeuchi; Feng Wei; Ronald Dubner; Ke Ren
Journal:  Eur J Pharmacol       Date:  2011-09-21       Impact factor: 4.432

2.  Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing.

Authors:  Maureen S Riedl; Patrick D Braun; Kelley F Kitto; Samuel A Roiko; Lorraine B Anderson; Christopher N Honda; Carolyn A Fairbanks; Lucy Vulchanova
Journal:  J Neurosci       Date:  2009-10-21       Impact factor: 6.167

3.  Regulation of mGluR1 on the Expression of PKC and NMDAR in Aluminum-Exposed PC12 Cells.

Authors:  Chanting He; Xiaoyan Zhao; Huan Li; Fei Wang; Jingsi Zhang; Yanni Wang; Yingchao Han; Chunman Yuan; Qiao Niu
Journal:  Neurotox Res       Date:  2021-01-19       Impact factor: 3.911

4.  Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.

Authors:  Rita Nyilas; Laura C Gregg; Ken Mackie; Masahiko Watanabe; Andreas Zimmer; Andrea G Hohmann; István Katona
Journal:  Eur J Neurosci       Date:  2009-05-09       Impact factor: 3.386

5.  mGluR5 antagonists that block calcium mobilization in vitro also reverse (S)-3,5-DHPG-induced hyperalgesia and morphine antinociceptive tolerance in vivo.

Authors:  Bichoy H Gabra; Forrest L Smith; Hernán A Navarro; F Ivy Carroll; William L Dewey
Journal:  Brain Res       Date:  2007-10-12       Impact factor: 3.252

6.  Role of Fyn-mediated NMDA receptor function in prediabetic neuropathy in mice.

Authors:  Meng Suo; Ping Wang; Mengyuan Zhang
Journal:  J Neurophysiol       Date:  2016-05-04       Impact factor: 2.714

7.  Endogenous analgesia, dependence, and latent pain sensitization.

Authors:  Bradley K Taylor; Gregory Corder
Journal:  Curr Top Behav Neurosci       Date:  2014

8.  Whole blood transcriptomic profiles can differentiate vulnerability to chronic low back pain.

Authors:  Susan G Dorsey; Cynthia L Renn; Mari Griffioen; Cameron B Lassiter; Shijun Zhu; Heather Huot-Creasy; Carrie McCracken; Anup Mahurkar; Amol C Shetty; Colleen K Jackson-Cook; Hyungsuk Kim; Wendy A Henderson; Leorey Saligan; Jessica Gill; Luana Colloca; Debra E Lyon; Angela R Starkweather
Journal:  PLoS One       Date:  2019-05-16       Impact factor: 3.240

9.  Peripheral NMDA Receptors Mediate Antidromic Nerve Stimulation-Induced Tactile Hypersensitivity in the Rat.

Authors:  Jun Ho Jang; Taick Sang Nam; Jaebeom Jun; Se Jung Jung; Dong-Wook Kim; Joong Woo Leem
Journal:  Mediators Inflamm       Date:  2015-12-03       Impact factor: 4.711

10.  Transcriptomic and behavioural characterisation of a mouse model of burn pain identify the cholecystokinin 2 receptor as an analgesic target.

Authors:  Kathleen Yin; Jennifer R Deuis; Richard J Lewis; Irina Vetter
Journal:  Mol Pain       Date:  2016-08-28       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.